Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen *
Pharmacy Only: Prescription
Show product notice

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Summary of Product Characteristics last updated on 18/7/2022 Download PDF

Product Notice

Discontinued Strength Notice

Bydureon 2 mg Powder and Solvent for Prolonged-Release Suspension for Injection in Pre-Filled Pen has been discontinued. It is expected that stock will be depleted by September 2022.